Provided by Tiger Fintech (Singapore) Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc.

0.7824
+0.073410.35%
Post-market: 0.7577-0.0247-3.16%19:51 EDT
Volume:323.02K
Turnover:249.22K
Market Cap:36.57M
PE:-0.87
High:0.8000
Open:0.6969
Low:0.6958
Close:0.7090
Loading ...
Aug 07, 2024

Correspondence

Form CORRESP - Correspondence
Jul 09, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 29, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2024

Correspondence

Form CORRESP - Correspondence
Nov 30, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 18, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]